04764nam a22005535i 4500 978-3-031-52696-1 DE-He213 20251030112100.0 cr nn 008mamaa 240527s2024 sz | s |||| 0|eng d 9783031526961 978-3-031-52696-1 10.1007/978-3-031-52696-1 doi RC705-779 MJL bicssc MED079000 bisacsh MJL thema Obesity and Lung Disease [electronic resource] : A Guide to Pathophysiology, Evaluation, and Management / edited by Anne E. Dixon, Erick Forno. 2nd ed. 2024. Cham : Springer International Publishing : Imprint: Humana, 2024. IX, 411 p. 41 illus., 30 illus. in color. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Respiratory Medicine, 2197-7380 SECTION I: Pathophysiology of Obesity and Lung Disease -- Airway Physiology and Lung Function -- Immune Function and Host Defense -- The Microbiome -- Metabolic Dysregulation -- Genetics and Genomics -- Diet and Nutrition -- SECTION II: Obesity and Respiratory Diseases -- Obstructive Sleep Apnea -- Obesity Hypoventilation Syndrome -- Asthma: Epidemiology and Clinical Presentation -- Asthma: Endotypes and Mechanisms -- Asthma: Management -- Chronic Obstructive Pulmonary Disease -- Pulmonary Hypertension -- Thromboembolic Disease -- Lung Transplant -- Respiratory Infections (Including COVID19) -- Lung Health in Pediatrics -- SECTION III: Obesity and Critical Care -- ALI and ARDS -- Mechanical Ventilation -- COVID19 in the ICU. This new edition provides a fully updated guide to obesity’s relation to lung disease. Over forty percent of the U.S. population is obese, and obesity is increasing in much of the world. Obesity has a major impact on health conditions such as diabetes and cardiovascular disease. The effects of obesity on lung disease have drawn increasing attention in recent years. Furthermore, the COVID pandemic has dramatically illustrated how obesity affects respiratory disease, constitutes a major risk factor for COVID-19, and presents challenges to pulmonary care in the ICU. Obesity changes physiology, immune and metabolic function, and is associated with changes in diet and the microbiome, all of which combine to have a major impact on the pathogenesis of respiratory diseases. Obesity is thus a risk factor for many respiratory diseases such as asthma, pulmonary hypertension, thromboembolic disease, obstructive sleep apnea and ARDS. Obesity also complicates the management of many other respiratory diseases and conditions such as COPD, thromboembolic disease, and the care of the critically ill patient. The objectives of this book are three-fold: To review how physiological, immune and metabolic factors might contribute to lung disease. To discuss the impact of obesity on common lung diseases To outline important considerations in the management of critically ill obese patients. There have been major advances in our understanding of the relationship between obesity and lung disease since the first edition in 2013, in addition to the major lessons learned about the importance of obesity during the COVID-19 pandemic. This has led to the addition of eight new chapters on topics such as, the microbiome, lung transplant, and COVID-19 in the ICU. This is an ideal guide for all clinicians taking care of patients with pulmonary and critical care diseases, as well as basic and translational scientists interested in how obesity affects respiratory health. Respiratory organs Diseases. 77494 Primary care (Medicine). 64645 Critical care medicine. 63042 Pneumology. 77495 Primary Care Medicine. 64645 Intensive Care Medicine. 73198 Dixon, Anne E. editor. edt http://id.loc.gov/vocabulary/relators/edt 77496 Forno, Erick. editor. edt http://id.loc.gov/vocabulary/relators/edt 77497 SpringerLink (Online service) Springer Nature eBook Printed edition: 9783031526954 Printed edition: 9783031526978 Printed edition: 9783031526985 Respiratory Medicine, 2197-7380 77498 https://doi.org/10.1007/978-3-031-52696-1 ZDB-2-SME ZDB-2-SXM 60151 60151